Profound Medical 2023 Virtual Analyst & Investor Day Agenda
10 oct. 2023 16h30 HE
|
Profound Medical Corp.
TORONTO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost
25 sept. 2023 16h05 HE
|
Profound Medical Corp.
TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Save the Date: Profound Medical to Host Virtual Analyst & Investor Day on October 13
21 sept. 2023 08h00 HE
|
Profound Medical Corp.
TORONTO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in the 2023 Cantor Global Healthcare Conference
19 sept. 2023 16h45 HE
|
Profound Medical Corp.
TORONTO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces At-the-Market Offering of up to US$30,000,000
06 sept. 2023 19h23 HE
|
Profound Medical Corp.
TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) announces that it has established an at-the-market equity program (the “ATM...
Profound Medical Announces Second Quarter 2023 Financial Results
09 août 2023 16h05 HE
|
Profound Medical Corp.
TORONTO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow
02 août 2023 16h30 HE
|
Profound Medical Corp.
TORONTO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases
02 juin 2023 13h40 HE
|
Profound Medical Corp.
TORONTO, June 02, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Upcoming Investor Events
30 mai 2023 08h00 HE
|
Profound Medical Corp.
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference
18 mai 2023 08h00 HE
|
Profound Medical Corp.
TORONTO, May 18, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...